Acquisition History Guava Technologies was acquired by Merck Millipore in 2008, indicating a strong corporate lineage and potential integration with established distribution channels, enterprise procurement programs, and a preference for validated supply chains.

Mid-market Scale With 51-200 employees and annual revenue in the 10–25 million range, Guava Technologies sits in a mid-market tier that often seeks scalable biotech solutions, collaboration-ready partnerships, and cost-effective vendor options aligned with larger suppliers.

Biotech Focus Operating in biotechnology research, the company presents opportunities for advanced lab reagents, instrumentation, and consumables, as well as potential co-development or customization projects aligned with R&D workflows.

Public Records Signal Public acquisition history and a clearly defined parent company (Merck Millipore) may facilitate formal procurement conversations, contract standardization, and risk-averse purchasing behavior favorable to established vendors.

Growth Opportunit ies Given a solid revenue base and exposure to large enterprise players in life sciences, there are potential cross-sell opportunities into related instruments, software for lab efficiency, and scalable services that support expanding R&D programs.